- WuXi Biologics Achieved Remarkable Results in 2019
- WuXi Biologics Completes Weather-Tight Seal of its Biologics Manufacturing Facility in Ireland
- WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
- WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321
- WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
- WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
- WuXi Biologics Provides Back-to-work Operation Update Related to the Coronavirus Outbreak
- WuXi Biologics Provides Operation Update Related to the Coronavirus Outbreak
- WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus
- WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
Wuxi Biologics Cayman Inc (2269:HKG) closed at 100.00, -19.22% below its 52-week high of 123.80, set on Mar 12, 2020.
65.00Jun 25 2019123.80Mar 12 2020
Markit short selling activity
|Market cap||129.76bn HKD|
|EPS (TTM)||0.834 |
Data delayed at least 15 minutes, as of Mar 27 2020 08:08 BST.